MTEX

Mannatech is a shrinking network-marketing wellness business, and the shrinkage is the whole story. Revenue has fallen every year since 2021 — $160M → $137M → $132M → $118M → $108M — an ~8.3% decline in FY2025 (still -6.8% on a constant-dollar basis, so this isn't just FX). The MD&A pins the model on ~114,000 active associates and preferred customers and admits new-associate fees are the 'leading indicator' for long-term success; a distributor base that can't grow in a mature MLM is a structural, not cyclical, problem, and management liquidated its Denmark entity in 2025. Gross margin is genuinely strong at 74.9%, but that quality can't offset a top line that keeps eroding and operations that ran an operating LOSS of $0.4M versus $1.4M operating income a year ago.

The headline -$15.2M net loss (-$8.00 diluted EPS) is heavily distorted by ~$12.3M of non-cash income-tax charges — $11.5M deferred tax expense plus a $1.7M valuation allowance against DTAs, driven by 'decreased domestic earnings' and doubt the company will earn enough to use those assets. Stripping that out, the business is roughly breakeven, so the loss overstates the operational damage. But the reason for the charge — management's own admission that future domestic earnings are too uncertain to realize tax benefits — is itself a bearish tell, and the cash figures corroborate it: operating cash flow swung to -$2.96M, cash fell 45.7% to $6.18M, and capex more than quadrupled to $1.35M. That is real cash leaving a very small company.